ETFRF1

Chr 12

electron transfer flavoprotein regulatory factor 1

Also known as: LYRM5

The protein regulates the electron transfer flavoprotein by promoting flavin removal from the ETF holoenzyme and participates in the mitochondrial respiratory electron transport chain. Mutations cause multiple acyl-CoA dehydrogenase deficiency, an autosomal recessive disorder affecting fatty acid oxidation that can present from the neonatal period through adulthood with episodes of hypoglycemia, metabolic acidosis, and muscle weakness. The gene shows very high constraint against loss-of-function variants, indicating mutations are likely to have significant clinical consequences.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
0
Pubs (1 yr)
37
P/LP submissions
P/LP missense
1.96
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryETFRF1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
37 unique Pathogenic / Likely Pathogenic· 5 VUS of 45 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.96LOEUF
pLI 0.000
Z-score -1.88
OE 2.12 (0.971.96)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.43Z-score
OE missense 1.19 (0.941.51)
49 obs / 41.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE2.12 (0.971.96)
00.351.4
Missense OE1.19 (0.941.51)
00.61.4
Synonymous OE0.93
01.21.6
LoF obs/exp: 7 / 3.3Missense obs/exp: 49 / 41.3Syn Z: 0.20
DN
0.75top 25%
GOF
0.6638th %ile
LOF
0.3065th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

45 submitted variants in ClinVar

Classification Summary

Pathogenic35
Likely Pathogenic2
VUS5
Likely Benign1
35
Pathogenic
2
Likely Pathogenic
5
VUS
1
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
35
Likely Pathogenic
2
VUS
5
Likely Benign
1
Benign
0
Total43

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ETFRF1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found